Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
European Journal of Cancer2022Vol. 174, pp. 68–77
Citations Over TimeTop 1% of 2022 papers
ZhiCheng Lai, Minke He, Xiaoyun Bu, Yu-Jie Xu, YeXing Huang, Dongsheng Wen, QiJiong Li, Li Xu, YaoJun Zhang, Wei Wei, MinShan Chen, Anna Kan, Ming Shi
Related Papers
- → Interstitial Lung Disease Associated with Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin(2010)4 cited
- → FOLFOX-4 Combination Chemotherapy as a First-line Treatment in Patients with Advanced Gastric Cancer(2012)2 cited
- The Efficacy and Toxicity of FOLFOX Regimen(A Combination of Leucovorin and Fluorouracil with Oxaliplatin)as First-Line Treatment of Metastatic Colorectal Cancer(2009)
- → Adjuvant FOLFOX Treatment for Stage III Colorectal Cancer: Why Patients Quit FOLFOX?(2017)
- Oxaliplatin, 5-Fluorouracil, Leucovorin 복합항암화학요법 중에 발생한 간질성 폐질환 1예(2010)